img

Global OTC Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global OTC Drug Market Insights, Forecast to 2034

Non-prescription drugs refer to drugs that can be purchased for the convenience of the public without a prescription from a physician or other medical professional. The general public can use the drugs on their own discretion according to the drug labels and instructions.
Market Analysis and InsightsGlobal OTC Drug Market
Global OTC Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, OTC Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global OTC Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global OTC Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer HealthCare
GlaxoSmithKline(GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
Segment by Type
Class A OTC Drug
Class B OTC Drug

Segment by Application


Hospital
Clinic
Household
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, OTC Drug introduction, etc. OTC Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of OTC Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Class A OTC Drug
1.2.3 Class B OTC Drug
1.3 Market by Application
1.3.1 Global OTC Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Drug Market Perspective (2018-2029)
2.2 Global OTC Drug Growth Trends by Region
2.2.1 OTC Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Drug Historic Market Size by Region (2018-2024)
2.2.3 OTC Drug Forecasted Market Size by Region (2024-2029)
2.3 OTC Drug Market Dynamics
2.3.1 OTC Drug Industry Trends
2.3.2 OTC Drug Market Drivers
2.3.3 OTC Drug Market Challenges
2.3.4 OTC Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue OTC Drug by Players
3.1.1 Global OTC Drug Revenue by Players (2018-2024)
3.1.2 Global OTC Drug Revenue Market Share by Players (2018-2024)
3.2 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of OTC Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global OTC Drug Market Concentration Ratio
3.4.1 Global OTC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Drug Revenue in 2022
3.5 Global Key Players of OTC Drug Head office and Area Served
3.6 Global Key Players of OTC Drug, Product and Application
3.7 Global Key Players of OTC Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Drug Breakdown Data by Type
4.1 Global OTC Drug Historic Market Size by Type (2018-2024)
4.2 Global OTC Drug Forecasted Market Size by Type (2024-2029)
5 OTC Drug Breakdown Data by Application
5.1 Global OTC Drug Historic Market Size by Application (2018-2024)
5.2 Global OTC Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America OTC Drug Market Size (2018-2029)
6.2 North America OTC Drug Market Size by Type
6.2.1 North America OTC Drug Market Size by Type (2018-2024)
6.2.2 North America OTC Drug Market Size by Type (2024-2029)
6.2.3 North America OTC Drug Market Share by Type (2018-2029)
6.3 North America OTC Drug Market Size by Application
6.3.1 North America OTC Drug Market Size by Application (2018-2024)
6.3.2 North America OTC Drug Market Size by Application (2024-2029)
6.3.3 North America OTC Drug Market Share by Application (2018-2029)
6.4 North America OTC Drug Market Size by Country
6.4.1 North America OTC Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America OTC Drug Market Size by Country (2018-2024)
6.4.3 North America OTC Drug Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe OTC Drug Market Size (2018-2029)
7.2 Europe OTC Drug Market Size by Type
7.2.1 Europe OTC Drug Market Size by Type (2018-2024)
7.2.2 Europe OTC Drug Market Size by Type (2024-2029)
7.2.3 Europe OTC Drug Market Share by Type (2018-2029)
7.3 Europe OTC Drug Market Size by Application
7.3.1 Europe OTC Drug Market Size by Application (2018-2024)
7.3.2 Europe OTC Drug Market Size by Application (2024-2029)
7.3.3 Europe OTC Drug Market Share by Application (2018-2029)
7.4 Europe OTC Drug Market Size by Country
7.4.1 Europe OTC Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe OTC Drug Market Size by Country (2018-2024)
7.4.3 Europe OTC Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China OTC Drug Market Size (2018-2029)
8.2 China OTC Drug Market Size by Type
8.2.1 China OTC Drug Market Size by Type (2018-2024)
8.2.2 China OTC Drug Market Size by Type (2024-2029)
8.2.3 China OTC Drug Market Share by Type (2018-2029)
8.3 China OTC Drug Market Size by Application
8.3.1 China OTC Drug Market Size by Application (2018-2024)
8.3.2 China OTC Drug Market Size by Application (2024-2029)
8.3.3 China OTC Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia OTC Drug Market Size (2018-2029)
9.2 Asia OTC Drug Market Size by Type
9.2.1 Asia OTC Drug Market Size by Type (2018-2024)
9.2.2 Asia OTC Drug Market Size by Type (2024-2029)
9.2.3 Asia OTC Drug Market Share by Type (2018-2029)
9.3 Asia OTC Drug Market Size by Application
9.3.1 Asia OTC Drug Market Size by Application (2018-2024)
9.3.2 Asia OTC Drug Market Size by Application (2024-2029)
9.3.3 Asia OTC Drug Market Share by Application (2018-2029)
9.4 Asia OTC Drug Market Size by Region
9.4.1 Asia OTC Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia OTC Drug Market Size by Region (2018-2024)
9.4.3 Asia OTC Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America OTC Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America OTC Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America OTC Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America OTC Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America OTC Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America OTC Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America OTC Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America OTC Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America OTC Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America OTC Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America OTC Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America OTC Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America OTC Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Details
11.1.2 Bayer HealthCare Business Overview
11.1.3 Bayer HealthCare OTC Drug Introduction
11.1.4 Bayer HealthCare Revenue in OTC Drug Business (2018-2024)
11.1.5 Bayer HealthCare Recent Developments
11.2 GlaxoSmithKline(GSK)
11.2.1 GlaxoSmithKline(GSK) Company Details
11.2.2 GlaxoSmithKline(GSK) Business Overview
11.2.3 GlaxoSmithKline(GSK) OTC Drug Introduction
11.2.4 GlaxoSmithKline(GSK) Revenue in OTC Drug Business (2018-2024)
11.2.5 GlaxoSmithKline(GSK) Recent Developments
11.3 Johnson&Johnson
11.3.1 Johnson&Johnson Company Details
11.3.2 Johnson&Johnson Business Overview
11.3.3 Johnson&Johnson OTC Drug Introduction
11.3.4 Johnson&Johnson Revenue in OTC Drug Business (2018-2024)
11.3.5 Johnson&Johnson Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer OTC Drug Introduction
11.4.4 Pfizer Revenue in OTC Drug Business (2018-2024)
11.4.5 Pfizer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi OTC Drug Introduction
11.5.4 Sanofi Revenue in OTC Drug Business (2018-2024)
11.5.5 Sanofi Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca OTC Drug Introduction
11.6.4 AstraZeneca Revenue in OTC Drug Business (2018-2024)
11.6.5 AstraZeneca Recent Developments
11.7 BioGaia
11.7.1 BioGaia Company Details
11.7.2 BioGaia Business Overview
11.7.3 BioGaia OTC Drug Introduction
11.7.4 BioGaia Revenue in OTC Drug Business (2018-2024)
11.7.5 BioGaia Recent Developments
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Details
11.8.2 Bristol Myers Squibb Business Overview
11.8.3 Bristol Myers Squibb OTC Drug Introduction
11.8.4 Bristol Myers Squibb Revenue in OTC Drug Business (2018-2024)
11.8.5 Bristol Myers Squibb Recent Developments
11.9 Bukwang Pharmaceutica
11.9.1 Bukwang Pharmaceutica Company Details
11.9.2 Bukwang Pharmaceutica Business Overview
11.9.3 Bukwang Pharmaceutica OTC Drug Introduction
11.9.4 Bukwang Pharmaceutica Revenue in OTC Drug Business (2018-2024)
11.9.5 Bukwang Pharmaceutica Recent Developments
11.10 Chr. Hansen
11.10.1 Chr. Hansen Company Details
11.10.2 Chr. Hansen Business Overview
11.10.3 Chr. Hansen OTC Drug Introduction
11.10.4 Chr. Hansen Revenue in OTC Drug Business (2018-2024)
11.10.5 Chr. Hansen Recent Developments
11.11 Cipla
11.11.1 Cipla Company Details
11.11.2 Cipla Business Overview
11.11.3 Cipla OTC Drug Introduction
11.11.4 Cipla Revenue in OTC Drug Business (2018-2024)
11.11.5 Cipla Recent Developments
11.12 CoLucid
11.12.1 CoLucid Company Details
11.12.2 CoLucid Business Overview
11.12.3 CoLucid OTC Drug Introduction
11.12.4 CoLucid Revenue in OTC Drug Business (2018-2024)
11.12.5 CoLucid Recent Developments
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Details
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo OTC Drug Introduction
11.13.4 Daiichi Sankyo Revenue in OTC Drug Business (2018-2024)
11.13.5 Daiichi Sankyo Recent Developments
11.14 Friggs
11.14.1 Friggs Company Details
11.14.2 Friggs Business Overview
11.14.3 Friggs OTC Drug Introduction
11.14.4 Friggs Revenue in OTC Drug Business (2018-2024)
11.14.5 Friggs Recent Developments
11.15 DSM
11.15.1 DSM Company Details
11.15.2 DSM Business Overview
11.15.3 DSM OTC Drug Introduction
11.15.4 DSM Revenue in OTC Drug Business (2018-2024)
11.15.5 DSM Recent Developments
11.16 Eisai
11.16.1 Eisai Company Details
11.16.2 Eisai Business Overview
11.16.3 Eisai OTC Drug Introduction
11.16.4 Eisai Revenue in OTC Drug Business (2018-2024)
11.16.5 Eisai Recent Developments
11.17 Eli Lilly
11.17.1 Eli Lilly Company Details
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly OTC Drug Introduction
11.17.4 Eli Lilly Revenue in OTC Drug Business (2018-2024)
11.17.5 Eli Lilly Recent Developments
11.18 Herbalife
11.18.1 Herbalife Company Details
11.18.2 Herbalife Business Overview
11.18.3 Herbalife OTC Drug Introduction
11.18.4 Herbalife Revenue in OTC Drug Business (2018-2024)
11.18.5 Herbalife Recent Developments
11.19 Euradite
11.19.1 Euradite Company Details
11.19.2 Euradite Business Overview
11.19.3 Euradite OTC Drug Introduction
11.19.4 Euradite Revenue in OTC Drug Business (2018-2024)
11.19.5 Euradite Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global OTC Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Class A OTC Drug
Table 3. Key Players of Class B OTC Drug
Table 4. Global OTC Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global OTC Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global OTC Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global OTC Drug Market Share by Region (2018-2024)
Table 8. Global OTC Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global OTC Drug Market Share by Region (2024-2029)
Table 10. OTC Drug Market Trends
Table 11. OTC Drug Market Drivers
Table 12. OTC Drug Market Challenges
Table 13. OTC Drug Market Restraints
Table 14. Global OTC Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global OTC Drug Revenue Share by Players (2018-2024)
Table 16. Global Top OTC Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Drug as of 2022)
Table 17. Global OTC Drug Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by OTC Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of OTC Drug, Headquarters and Area Served
Table 20. Global Key Players of OTC Drug, Product and Application
Table 21. Global Key Players of OTC Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global OTC Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global OTC Drug Revenue Market Share by Type (2018-2024)
Table 25. Global OTC Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global OTC Drug Revenue Market Share by Type (2024-2029)
Table 27. Global OTC Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global OTC Drug Revenue Share by Application (2018-2024)
Table 29. Global OTC Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global OTC Drug Revenue Share by Application (2024-2029)
Table 31. North America OTC Drug Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America OTC Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America OTC Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America OTC Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America OTC Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America OTC Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America OTC Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe OTC Drug Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe OTC Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe OTC Drug Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe OTC Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe OTC Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe OTC Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe OTC Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China OTC Drug Market Size by Type (2018-2024) & (US$ Million)
Table 46. China OTC Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China OTC Drug Market Size by Application (2018-2024) & (US$ Million)
Table 48. China OTC Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia OTC Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia OTC Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia OTC Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia OTC Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia OTC Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia OTC Drug Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia OTC Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America OTC Drug Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America OTC Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America OTC Drug Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America OTC Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America OTC Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America OTC Drug Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America OTC Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. Bayer HealthCare Company Details
Table 64. Bayer HealthCare Business Overview
Table 65. Bayer HealthCare OTC Drug Product
Table 66. Bayer HealthCare Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 67. Bayer HealthCare Recent Developments
Table 68. GlaxoSmithKline(GSK) Company Details
Table 69. GlaxoSmithKline(GSK) Business Overview
Table 70. GlaxoSmithKline(GSK) OTC Drug Product
Table 71. GlaxoSmithKline(GSK) Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 72. GlaxoSmithKline(GSK) Recent Developments
Table 73. Johnson&Johnson Company Details
Table 74. Johnson&Johnson Business Overview
Table 75. Johnson&Johnson OTC Drug Product
Table 76. Johnson&Johnson Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 77. Johnson&Johnson Recent Developments
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer OTC Drug Product
Table 81. Pfizer Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 82. Pfizer Recent Developments
Table 83. Sanofi Company Details
Table 84. Sanofi Business Overview
Table 85. Sanofi OTC Drug Product
Table 86. Sanofi Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 87. Sanofi Recent Developments
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca OTC Drug Product
Table 91. AstraZeneca Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 92. AstraZeneca Recent Developments
Table 93. BioGaia Company Details
Table 94. BioGaia Business Overview
Table 95. BioGaia OTC Drug Product
Table 96. BioGaia Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 97. BioGaia Recent Developments
Table 98. Bristol Myers Squibb Company Details
Table 99. Bristol Myers Squibb Business Overview
Table 100. Bristol Myers Squibb OTC Drug Product
Table 101. Bristol Myers Squibb Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 102. Bristol Myers Squibb Recent Developments
Table 103. Bukwang Pharmaceutica Company Details
Table 104. Bukwang Pharmaceutica Business Overview
Table 105. Bukwang Pharmaceutica OTC Drug Product
Table 106. Bukwang Pharmaceutica Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 107. Bukwang Pharmaceutica Recent Developments
Table 108. Chr. Hansen Company Details
Table 109. Chr. Hansen Business Overview
Table 110. Chr. Hansen OTC Drug Product
Table 111. Chr. Hansen Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 112. Chr. Hansen Recent Developments
Table 113. Cipla Company Details
Table 114. Cipla Business Overview
Table 115. Cipla OTC Drug Product
Table 116. Cipla Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 117. Cipla Recent Developments
Table 118. CoLucid Company Details
Table 119. CoLucid Business Overview
Table 120. CoLucid OTC Drug Product
Table 121. CoLucid Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 122. CoLucid Recent Developments
Table 123. Daiichi Sankyo Company Details
Table 124. Daiichi Sankyo Business Overview
Table 125. Daiichi Sankyo OTC Drug Product
Table 126. Daiichi Sankyo Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 127. Daiichi Sankyo Recent Developments
Table 128. Friggs Company Details
Table 129. Friggs Business Overview
Table 130. Friggs OTC Drug Product
Table 131. Friggs Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 132. Friggs Recent Developments
Table 133. DSM Company Details
Table 134. DSM Business Overview
Table 135. DSM OTC Drug Product
Table 136. DSM Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 137. DSM Recent Developments
Table 138. Eisai Company Details
Table 139. Eisai Business Overview
Table 140. Eisai OTC Drug Product
Table 141. Eisai Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 142. Eisai Recent Developments
Table 143. Eli Lilly Company Details
Table 144. Eli Lilly Business Overview
Table 145. Eli Lilly OTC Drug Product
Table 146. Eli Lilly Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 147. Eli Lilly Recent Developments
Table 148. Herbalife Company Details
Table 149. Herbalife Business Overview
Table 150. Herbalife OTC Drug Product
Table 151. Herbalife Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 152. Herbalife Recent Developments
Table 153. Euradite Company Details
Table 154. Euradite Business Overview
Table 155. Euradite OTC Drug Product
Table 156. Euradite Revenue in OTC Drug Business (2018-2024) & (US$ Million)
Table 157. Euradite Recent Developments
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global OTC Drug Market Share by Type: 2022 VS 2029
Figure 3. Class A OTC Drug Features
Figure 4. Class B OTC Drug Features
Figure 5. Global OTC Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global OTC Drug Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Household Case Studies
Figure 10. OTC Drug Report Years Considered
Figure 11. Global OTC Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global OTC Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global OTC Drug Market Share by Region: 2022 VS 2029
Figure 14. Global OTC Drug Market Share by Players in 2022
Figure 15. Global Top OTC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by OTC Drug Revenue in 2022
Figure 17. North America OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America OTC Drug Market Share by Type (2018-2029)
Figure 19. North America OTC Drug Market Share by Application (2018-2029)
Figure 20. North America OTC Drug Market Share by Country (2018-2029)
Figure 21. United States OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe OTC Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe OTC Drug Market Share by Type (2018-2029)
Figure 25. Europe OTC Drug Market Share by Application (2018-2029)
Figure 26. Europe OTC Drug Market Share by Country (2018-2029)
Figure 27. Germany OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China OTC Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China OTC Drug Market Share by Type (2018-2029)
Figure 35. China OTC Drug Market Share by Application (2018-2029)
Figure 36. Asia OTC Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia OTC Drug Market Share by Type (2018-2029)
Figure 38. Asia OTC Drug Market Share by Application (2018-2029)
Figure 39. Asia OTC Drug Market Share by Region (2018-2029)
Figure 40. Japan OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America OTC Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America OTC Drug Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America OTC Drug Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America OTC Drug Market Share by Country (2018-2029)
Figure 50. Brazil OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries OTC Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Bayer HealthCare Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 57. GlaxoSmithKline(GSK) Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 58. Johnson&Johnson Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 59. Pfizer Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 60. Sanofi Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 61. AstraZeneca Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 62. BioGaia Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 63. Bristol Myers Squibb Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 64. Bukwang Pharmaceutica Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 65. Chr. Hansen Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 66. Cipla Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 67. CoLucid Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 68. Daiichi Sankyo Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 69. Friggs Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 70. DSM Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 71. Eisai Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 72. Eli Lilly Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 73. Herbalife Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 74. Euradite Revenue Growth Rate in OTC Drug Business (2018-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries